» Authors » Bruce L Miller

Bruce L Miller

Explore the profile of Bruce L Miller including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 845
Citations 52490
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Coulborn S, Schafer R, Roy A, Sokolowski A, Cryns N, Leichter D, et al.
Ann Clin Transl Neurol . 2025 Mar; PMID: 40063407
Objective: Certain frontotemporal lobar degeneration subtypes, including TDP-A and B, can either occur sporadically or in association with specific genetic mutations. It is uncertain whether syndromic or imaging features previously...
2.
Wang H, Chang T, Dombroski B, Cheng P, Si Y, Tucci A, et al.
Mov Disord . 2025 Mar; PMID: 40055946
Background: The 17q21.31 region with various structural forms characterized by the H1/H2 haplotypes and three large copy number variations (CNVs) represents the strongest risk locus in progressive supranuclear palsy (PSP)....
3.
Zegarra-Valdivia J, Shany-Ur T, Rijpma M, Callahan P, Poorzand P, Grossman S, et al.
J Alzheimers Dis . 2025 Mar; :13872877251317683. PMID: 40026013
Background: Theory of mind (ToM) is crucial for socioemotional interaction. ToM deficits may explain behavioral changes in dementia, especially Alzheimer's disease (AD) and frontotemporal dementia (FTD). Objective: This study examined...
4.
Ulugut H, Mandelli M, Gilioli A, Ezzes Z, Pillai J, Baquirin D, et al.
medRxiv . 2025 Feb; PMID: 39974134
Semantic behavioral variant (also referred to as right temporal) frontotemporal dementia is a newly described syndrome associated with focal right anterior temporal lobe atrophy and a distinctive combination of behavioral...
5.
VandeVrede L, Cho H, Sanderson-Cimino M, Wekselman F, Cobigo Y, Gorno-Tempini M, et al.
JAMA Neurol . 2025 Feb; PMID: 39928343
Importance: Blood-based biomarkers for Alzheimer disease (AD) are clinically available, but their value is not well understood in syndromes typically associated with frontotemporal lobar degeneration syndromes (FTLD). Objective: To investigate...
6.
Johnson T, Tsoy E, Shen J, Rivera W, Lieu K, Salazar C, et al.
Neurocase . 2025 Feb; :1-10. PMID: 39924667
Alzheimer's disease (AD) symptomatology, while classically studied through the lens of amyloid-β and tau burden, is likely also influenced by multiple-interacting co-pathologies like vascular disease and dysmetabolism. These co-pathologies, especially...
7.
Wang L, Hu W, Dong F, Sheng C, Wu J, Han Y, et al.
Geroscience . 2025 Jan; PMID: 39888585
Brain network dynamics have been extensively explored in patients with subjective cognitive decline (SCD). However, these studies are susceptible to individual differences, scanning parameters, and other confounding factors. Therefore, how...
8.
Miller Z, Hinkley L, Borghesani V, Mauer E, Shwe W, Mizuiri D, et al.
Cortex . 2024 Dec; 183:116-130. PMID: 39631179
Based on historic observations that children with reading disabilities were disproportionately both male and non-right-handed, and that early life insults of the left hemisphere were more frequent in boys and...
9.
Torres-Espin A, Radabaugh H, Treiman S, Fitzsimons S, Harvey D, Chou A, et al.
Sci Transl Med . 2024 Nov; 16(775):eadk3118. PMID: 39602511
Aberrant angiogenesis could contribute to the development of cognitive impairment and represent a therapeutic target for preventing dementia. However, most studies addressing angiogenesis and cognitive impairment focus on model organisms....
10.
Acosta-Uribe J, Pina Escudero S, Cochran J, Taylor J, Castruita P, Jonson C, et al.
medRxiv . 2024 Nov; PMID: 39574875
Background: Latin America's diverse genetic makeup, shaped by centuries of admixture, presents a unique opportunity to study Alzheimer's disease dementia (AD) and frontotemporal dementia (FTD). Our aim is to identify...